Search - tctmd.com

Displaying 421 - 440 of 1498

Sort: Relevancy | Date

Presentation TCT 2019

Take Home for Clinicians: DM and STEMI

Presenter: Dominick Angiolillo

September 26, 2019

Presentation TCT 2019

Take Home for Clinicians

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Presenter: John Forrest

September 26, 2019

Presentation TCT 2019

Severe Symptomatic AS and Moderate/Severe MR: Case Presentation and Management Strategies

Presenter: Anita Asgar

September 26, 2019

Presentation TCT 2019

The Value of Evaluating Shear Stress in Addition to FFR: A Better Predictor for Clinical Events?

Presenter: Habib Samady

September 26, 2019

Presentation TCT 2019

TAVR in Low-Flow Low-Gradient AS: Case Presentation(s), Diagnostic Algorithms, and Management Strategies

Presenter: Howard Herrmann

September 26, 2019

Presentation TCT 2019

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Presenter: David Hildick-Smith

September 26, 2019

Presentation TCT 2019

CLI Vascular Team: Vascular Surgery Perspective

Presenter: Frank Veith

September 26, 2019

Presentation TCT 2019

TAVR in a Small Aortic Annulus: Case Presentation and Management Strategies

Presenter: Itshac Itsik Ben-dor

September 26, 2019

Presentation TCT 2019

CLI Vascular Team: IC Perspective

Presenter: Christopher J White

September 26, 2019

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

Presentation TCT 2019

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Conduction Disturbances After TAVR: Current Thinking and Clinical Relevance

Presenter: Tamim Nazif

September 26, 2019

Presentation TCT 2019

PCI for HBD Patients in Japan: Current Clinical Treatment and Post-Market Treatment

Presenter: Junya Ako

September 26, 2019

Presentation TCT 2019

ARC Definition of High Bleeding Risk: Global Impact on HBR PCI Clinical Studies?

Presenter: Hans-Peter Stoll

September 26, 2019

Presentation TCT 2019

Case Presentation, Evolving Technology, and Clinical Trial Status

Presenter: Torsten Vahl

September 26, 2019

Presentation TCT 2019

Machine Learning for Risk Prediction of Future Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Jin Sup

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Advertisement

Take Home for Clinicians: DM and STEMI

Take Home for Clinicians

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Severe Symptomatic AS and Moderate/Severe MR: Case Presentation and Management Strategies

The Value of Evaluating Shear Stress in Addition to FFR: A Better Predictor for Clinical Events?

TAVR in Low-Flow Low-Gradient AS: Case Presentation(s), Diagnostic Algorithms, and Management Strategies

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

CLI Vascular Team: Vascular Surgery Perspective

TAVR in a Small Aortic Annulus: Case Presentation and Management Strategies

CLI Vascular Team: IC Perspective

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward

Conduction Disturbances After TAVR: Current Thinking and Clinical Relevance

PCI for HBD Patients in Japan: Current Clinical Treatment and Post-Market Treatment

ARC Definition of High Bleeding Risk: Global Impact on HBR PCI Clinical Studies?

Case Presentation, Evolving Technology, and Clinical Trial Status

Machine Learning for Risk Prediction of Future Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Clinical Rationale for LAA Closure After AF Ablation

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content